Author: trainitright

Attract, Retain & Motivate Top Talent with Stafits’ Employee Wellness Benefit Packages

Toronto, ON - With the goal of allowing businesses the opportunity to attract the best and brightest of employees, Toronto-based Stafits provides Wellness Benefits to employers. Wellness Benefits are generally viewed as a good investment on the part of employers. Studies have shown that when employees choose to take advantage of Wellness Benefits, improvements in mental, physical and financial health are noted, and traditional health care costs are lowered as a result.

While the concept of Wellness Benefits is nothing new, these types of benefits usually cover activities such as yoga classes, nutrition classes or perhaps a speaker on financial planning, to name just a few examples. But according to Stafits founder Gil Koren, the biggest issue with these types of wellness benefits is engagement.

“There’s always a small group of employees who will happily accept anything you offer,” says Koren. “But for the majority, it is hard to find an initiative that really drives engagement.  No matter how good a certain program could potentially be, if no one is using it, it’s just a waste of money.”

Which is the reason why Stafits came up with the unique idea of offering a vacation plan.  

“What do all employees crave more than anything? A vacation, of course!” explains Koren. “Here’s a solution that will recharge and relax, help relieve stress, reduce burnout, improve morale and increase productivity. To achieve this, we offer a completely customized plan for each employer that is fully managed by us… and all for less than a cost of a cup of coffee per employee, per month.”

Description: http://www.getnews.info/uploads/f1164bd491fdc2071c8b685ca5be3fcd.jpg

The program works by giving employees contributions to their travel plan on a monthly basis. Employer involvement is kept to a minimum. Stafits takes care of all the details, even to the point of helping employees arrange their vacations.

As employers recognize the advantages behind the idea of a employee vacation plan, Stafits is becoming an increasingly popular choice. Businesses of all types and sizes share their positive experiences with the program on the Stafits testimonials page.


Video Link: http://www.youtube.com/embed/byjQf5WH4CU

About Stafits:

Comprised of a group of innovative business owners, Toronto-based Stafits was founded in 2017 as a Wellness Benefit provider. Based on the premise that “A happy employee is a productive employee,” the company focuses on providing a staff retention plan that works by offering travel incentives to employees.

For more information, visit the website at www.stafits.com.

For more information on this press release visit: http://www.getnews.info/721351/attract-retain-motivate-top-talent-with-stafits-employee-wellness-benefit-packages.html

Ontario Liberals make it harder for smokers to quit, ignore scientific evidence: e-cigarette industry

 

TORONTO, May 2, 2018 /CNW/ - The Ontario government's new regulations dealing with electronic cigarettes will reduce access to a potentially life-saving technology for people who are trying to quit smoking, which will have a devastating effect on public health and the economy, according to officials with the Canadian Vaping Association (CVA), Canada's preeminent e-cigarette trade association.

In January, the Ontario government, led by Premier Kathleen Wynne, opened a public consultation on proposed regulations covering Bill 174, the Smoke-Free Ontario Act, 2017. However, on April 23, the Liberals announced that the draft regulations would be implemented without any amendments.

Those working within the industry warn that a regulation banning the use of e-cigarettes within specialty vape shops — which, under the law, will only be accessible to adults over 19 years of age — will make it impossible for them to show customers, who are looking to reduce the harms caused by smoking, how to use the devices, and prevent people from testing the products in-store.

As a result, many smokers will be discouraged from switching to e-cigarettes, which the Royal College of Physicians in the U.K. says is 95 per cent safer for one's health than smoking. This will have a detrimental effect on public health and harm the many small businesses that sell and manufacture e-cigarettes and related products in Ontario.

CVA president Shaun Casey said that the regulation demonstrates a lack of understanding of how much education and training it takes to transition people from smoking to vaping.

"This regulation will make the transition for adult smokers almost impossible, leading to fewer people finding and trying vaping, thereby reducing access for adult smokers and ultimately shutting down the industry and turning it over to less-effective Big Tobacco products to again dominate this space," he said.

Officials with the CVA say that while they understand the government's knee-jerk reaction to lump vaping in with existing indoor smoking bans, such a policy is not based on the latest scientific evidence. They point to a growing body of research showing that the second-hand vapour produced by e-cigarettes does not pose a risk to bystanders.

For example, Public Health England's "latest evidence review found that to date, there have been no identified health risks of passive vaping to bystanders," according to the U.K. government's website.

Likewise, a 2017 study from the Non-Smokers' Rights Association, a Canadian non-profit, shows that e-cigarette vapour dissipates after 30 seconds, whereas cigarette smoke lingers for upwards of 20 minutes. It concluded that, "Studies on e-cigarette vapour typically demonstrate very low toxicity, and no study to date has directly correlated exposure with long-term adverse health outcomes for bystanders."

A 2017 literature review conducted by researchers at the Centre for Addictions Research of BC at the University of Victoria also found that second-hand vapour is "far less toxic than cigarette smoke, often by several orders of magnitude," as it does not contain any "carbon monoxide and volatile organic compounds." They concluded that there is no evidence that second-hand vapour "poses significant second-hand health risks."

With an election looming, the CVA is calling on all parties to stand up for public health and small businesses in the province of Ontario by committing to allow adults to test and sample e-cigarettes within vape shops.

"The CVA and its membership are deeply committed to working with all three levels of government on fair and balanced legislation and regulations that are in the best interests of Canadians," said CVA executive director Darryl Tempest. "But we have serious concerns about the potential negative impacts that this regulation will have on both the vaping industry and on adult smokers in Ontario who seek a less harmful alternative."

The CVA (canadianvapingassociation.org) is a registered national not-for-profit organization, established as the voice of Canada's burgeoning vaping industry. Founded in 2014, the CVA represents e-cigarette retailers and manufacturers throughout the country.

SOURCE The Canadian Vaping Association

May is Bladder Cancer Awareness Month

Bladder cancer is the 5th most common cancer in Canada, yet the organization, Bladder Cancer Canada (BCC) and the disease itself are relatively unknown to the public. Bladder Cancer Canada is launching a campaign this May to promote awareness about Bladder Cancer Canada and the support services and information we provide to patients to help them through their journey.

TORONTO (April 30, 2018) - The month of May is Bladder Cancer Awareness month in Canada. Staff and volunteers at Bladder Cancer Canada have any exciting grassroots campaigned lined up to reach out to the more than 80,000 bladder cancer patients across Canada.

“Our year-round ‘See Red? See Your Doctor’ campaign continues to raise awareness about bladder cancer in the general public”, said Ken Bagshaw, Chair of Bladder Cancer Canada. “Our mission continues to raise general awareness, but we are putting a special emphasis on reaching out to those affected by bladder cancer and their support network to draw their attention to our organization and how we can offer support to them.”

Patient support, raising awareness and funding research into bladder cancer are the three main core mandates of Bladder Cancer Canada. The month of May is a focused effort through Bladder Cancer Canada’s communication channels and national network of volunteers to extend their outreach.

The May campaign will involve media interviews, social media stories and featured “community icons” lighting up yellow to help show that #YellowHelps through the efforts of the organization.

“Through the month of May we want to draw attention to Bladder Cancer Canada and our dedication to supporting our patient community”, commented Tammy Northam, Executive Director of Bladder Cancer Canada. “We encourage people to share the hashtag #YellowHelps to draw attention to all that we offer as an organization”, said Northam.

Canadians are invited to visit www.bladdercancercanada.org to find out how to get involved. Bladder Cancer Canada can also be found on Facebook, Instagram and on Twitter @BladderCancerCA. Let’s get the conversation going right across Canada about how #YellowHelps in assisting those facing #BladderCancer.

Authentic Italian Food and Gluten Free Unite

Pasta, Pizza, Pane Healthy for One and All!

 

 

Phoenix, AZ – 30th April 2018.  International Media Celebrity, Supermodel, Beauty, Lifestyle and Wellness expert Clarissa Burt has partnered with world renowned Chef Rita Romano to create “The Gluten Free Gastronomy Cookbook” in hard copy and digital versions. Comprised of 70 sumptuous Cucina Italiana recipes all without the dangers of gluten.  Finally, those with gluten intolerance and Celiac disease can savor mouth-watering Italian food.

 

Clarissa lived in Italy for 30 years and is highly gluten intolerant.  After countless trips in an ambulance to the emergency room, no doctor could ever diagnose the reason for her anaphylactic shocks.  "I never left home without an EpiPen.  The attacks were terrifying.  One minute I was fine and the next I looked like Shrek!  The itching would drive me crazy!!" Clarissa explains.   She approached Italian Chef Rita Romano for help who quickly came to the rescue.  An ecstatic Clarissa wants everyone to know Gluten Intolerance is really a ‘thing’!  Clarissa continues, “You can now enjoy pasta, pizza and pane without the dangerous side effects of gluten”!

 

“I genuinely love this book. As Italian Food Ambassador, food writer and cooking instructor, it is my duty to preserve and promote the deliciousness and uniqueness of our culinary heritage” says Ale Gambini. I’m happy to say that the Italian Gluten Free Gastronomy cookbook is a great example of how the most beloved cuisine in the world can be tasty, healthy and authentic even without the use of one of its staples: the wheat.  Simple and delicious gluten-free recipes, easy to make on a daily basis for authentic Italian meals. such as Antipasti (Appetizers) to Pasta, Risotti, Secondi (Main Dishes), Side Dishes, Salads and Desserts.  Big thumbs up to Clarissa and Rita!

 

 

Buy the hard copy book and digital versions on https://clarissaburt.shop/italian-gluten-free-gastronomy/

For more about Clarissa, www.ClarissaBurt.com

For more about Rita, www.RitasRecipes.com      ###

Discovery Explaining the Potential Cardiovascular Benefits of a Precision Therapy Based on the Genetic Profile

 

MONTREAL, April 26, 2018 /CNW Telbec/ - Researchers at the Montreal Heart Institute announced today that they have discovered the mechanism for the protective effects of reduced activity of the ADCY9 gene in atherosclerosis resulting from accumulation of fat in the artery walls. Indeed, a reduction of 65% of atherosclerosis occurs when the ADCY9 gene is not functional in mice, but only when another gene (CETP) is also absent. This benefit is explained by a marked reduction of inflammation in the arteries. These results have been published in the prestigious American scientific journal Circulation.

Drs Jean-Claude Tardif and Marie-Pierre Dubé from the Montreal Heart Institute had previously shown in a retrospective analysis a significant 39% reduction in the risk of cardiovascular events in patients receiving the CETP inhibitor dalcetrapib and having the AA genotype in the ADCY9 gene. This discovery has led DalCor Pharmaceuticals to launch the Dal-GenE study with 6000 patients that is presently taking place in 34 countries. This new discovery described today supports the underlying rationale for Dal-GenE and may explain the reasons for the  cardiovascular benefits occurring in patients who have the appropriate genetic profile.

«The benefits according to the ADCY9 gene profile may pave the way for the first precision cardiovascular therapy against atherosclerosis with dalcetrapib», stressed Dr Jean-Claude Tardif, Director of the Research Centre of the Montreal Heart Institute and Professor of medicine at the University of Montreal. « Given that cardiovascular diseases remain the first cause of mortality in the world and that atherosclerosis is its main source, our discovery may have an important impact by opening new pathways for research to bring to patients new therapies based on their genetic profile », continued Dr. Tardif.

« Precision cardiovascular medicine has the potential to transform healthcare, and our team shows through these discoveries its international leadership in this state-of-the-art field», stated Mélanie La Couture, Chief Executive Officer of the Montreal Heart Institute.

About the Montreal Heart Institute
Founded in 1954 by Dr. Paul David, the Montreal Heart Institute constantly aims for the highest standards of excellence in the cardiovascular field through its leadership in clinical and basic research, ultra-specialized care, professional training and prevention. It is part of the broad network of health excellence made up of Université de Montréal and its affiliated institutions.

About DalCor Pharmaceuticals
DalCor is developing precision treatments by genetically targeting patients that will derive clinical benefits. By integrating clinical and genetic insights, DalCor intends to deliver superior clinical cardiovascular outcomes. The company's development program, dalcetrapib, is intended to reduce cardiovascular events in a specific genetic subset of patients.

DalCor secured a worldwide exclusive license for dalcetrapib together with rights to the genetic marker for use with dalcetrapib and is sponsoring the dal-GenE study, which is planned to include 6,000 patients to prospectively confirm the results of the pharmacogenomic analysis in the dal-Outcomes study in a patient population with the AA genotype at the rs1967309 location in the ADCY9 gene.

DalCor Pharmaceuticals has offices in Montreal, San Mateo, Calif., Zug, Switzerland and Stockport, U.K. For more information, visit www.dalcorpharma.com

 

SOURCE Montreal Heart Institute Foundation

Why Eating Enough Calories and Working out is Important

You might think that the best way to remain thin is by reducing your daily calories to an extremely low level, but this dietary plan can lead to gaining weight along with ruining your overall health. The appropriate way to maintain your weight is by consuming an adequate amount of calories along with exercising several times each week. Here is why the combination of eating enough and exercising is more beneficial for your well-being.

Prevent Illness by Consuming Plenty of Nutrients

If you aren’t eating enough, then you won’t consume the right types of nutrients. When you don’t consume the proper level of vitamins and minerals, your immune system becomes depleted, making it more likely that you will develop an illness such as influenza or a cold. You can improve the condition of your immune system by making sure to eat a lot of lean protein, fresh produce and whole-grain foods.

Have a Strong Body by Exercising Frequently

It is important to exercise frequently so that your muscles are strong and your tendons are flexible. Some types of exercise will also improve the condition of your bones to prevent osteoporosis. Experts recommend exercising at least three times a week for 30 to 45 minutes, but in order to have enough energy for physical activity, you should consume a nutritious diet each day.

Do You Have an Eating Disorder?

When you are binge eating or not eating enough, you might have an eating disorder that requires treatment. Eating disorder treatment facilitiescan diagnose your type of eating disorder along with planning a course of treatments to help you overcome the problem. While in an eating disorder facility, you will participate in individual and group counseling sessions to determine why you have an issue with food.

Maintaining Your Mental Focus Each Day

Your brain requires nutrients so that you have stronger cognitive abilities. When you aren’t eating a proper diet, it can lead to a reduction in your brain’s activity, reducing your mental focus. In addition to eating nutritious foods, you must also exercise to enrich your body with additional oxygen that provides energy. If you can exercise outside, then you are also exposing your skin to sunlight that will help your body to manufacture additional vitamin D.

Have a Daily Dietary and Exercise Plan

If you forget to exercise or eat the right types of foods, then you should have a written daily dietary and exercise plan to keep you on track each day.

It's Time for Women to Stop Dying Unnecessarily. It's #TimeToSeeRed.

 

Heart & Stroke™ launches national awareness campaign to close the deadly gap in women's heart and brain health

TORONTO, April 25, 2018 /CNW/ - Heart disease and stroke claim the life of a woman in Canada every 17 minutes. Sex and gender blinders have caused too many women's lives to be cut short, and today, Heart & Stroke is standing up for women's heart and brain health equity with the launch of #TimeToSeeRed. This powerful awareness campaign is aimed at galvanizing Canadians to push for and make changes, and at a faster pace than we have seen in the past.

"Unfortunately, it's hard to fix problems you can't see," said Yves Savoie, CEO, Heart & Stroke. "So, we're using #TimeToSeeRed to draw attention to the problem, so we can work together – public, health professionals, health systems and governments – to close the gap in women's health."

Despite recent progress, women's heart and brain health is still vastly misunderstood. These diseases remain the leading cause of premature death for women in Canada – yet women don't even know it, wrongly presuming other diseases are more dangerous.

Alarmingly, not only are women under-aware of risks of heart disease and stroke, but the healthcare system lacks the proper diagnostic tools and therapies to properly diagnose and treat them. Two-thirds of heart disease and stroke clinical research still focuses on men, making it difficult to draw conclusions about the effects or risks of the diagnostic tools and therapies on women.

"Historically heart disease and stroke were viewed as men's diseases," said Dr. Paula Harvey, Director, Cardiovascular Research Program, Women's College Hospital. "Research was based on the incorrect assumption that what worked for a man would work for a woman, but it's not one-size-fits-all. We are now learning how women's physiology and hormonal changes put them at risk for heart disease and stroke in ways that are different than men. This knowledge needs to make its way into better diagnostics, treatments and support."

#TimeToSeeRed Debuts at SeeRed Talks

Heart & Stroke hosted SeeRed Talks in Toronto and Montreal on April 25th as the official kick-off to the campaign to ignite passion and inspire change. The SeeRed Talks were the first in a series of in-depth panel discussions with healthcare experts and women survivors expected to take place in regions across Canada to bring this issue to life and discuss solutions. The events were streamed live and are available on the Heart & Stroke Facebook Page allowing the organization to engage Canadians from coast to coast.

Audiences at the SeeRed Talks got a first look at the new campaign video —  an alarming depiction of the health inequities faced by women, which is meant to capture attention and drive people to learn more at heartandstroke.ca/women. The video will be shown in Cineplex theatres across the country and on digital channels, accompanied by a social media campaign and print ads.

"For nearly a decade, I had the signs of heart disease, but I let it slide," said Natalie Deane, heart disease survivor. "I was told by doctors that it was anxiety or stress because a holter monitor didn't detect a problem. It took years for me to be properly diagnosed, which could easily have been too late. I am honoured to share my story with Canadians to raise awareness for this important issue. I encourage all women to be proactive about getting the care they need."

Visit heartandstroke.ca/women to find information and stories that deepen understanding of the complex issues and provide different ways that people in Canada can get involved in solving it.

For more information about health inequities facing women, read Heart & Stroke's recent Heart Report here.

Heart & Stroke is proud to partner with Shoppers Drug Mart, based on their commitment to women's health called SHOPPERS LOVE. YOU.  We gratefully acknowledge the generous support of our Founding Partner, SHOPPERS LOVE. YOU. Together, we're committed to saving women's lives by advancing women's heart and brain health in Canada.

About Heart & Stroke
Life. We don't want you to miss it. That's why Heart & Stroke leads the fight against heart disease and stroke. We must generate the next medical breakthroughs, so Canadians don't miss out on precious moments. Together, we are working to prevent disease, save lives and promote recovery through research, health promotion and public policy.

About SHOPPERS LOVE. YOU.
SHOPPERS LOVE. YOU.  is the identity for our long-standing commitment for women's health. To help women live their best lives, the SHOPPERS LOVE. YOU. program is designed to help women stay focused on making their own health a priority by connecting them to the expertise of our partners at leading women's health organizations and to others in support of women's health initiatives across Canada.  Learn more at shoppersloveyou.ca.

SOURCE Heart & Stroke

Experts Gather in Montreal to Develop International Research Agenda on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

 

MONTREAL, April 25, 2018 /CNW Telbec/ - International experts will participate in the first-ever Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Canadian Collaborative Team Conference on May 3–5, 2018 at CHU Sainte-Justine.  The conference will bring together 250 researchers and healthcare professionals from various disciplines to develop an international research agenda for this debilitating disease, for which there is no known cause or effective treatment.

"I am extremely encouraged by the interest shown by leading researchers and clinicians, who recognize the importance of establishing research priorities that will advance our understanding of ME/CFS and identify new strategies for treating patients," says Dr. Alain Moreau, Head, Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, CHU Sainte-Justine Research Center and Scientific Chair of the Conference.

The conference will focus on:

  • Methods to properly diagnose patients with ME/CFS;
  • The role of biomarkers in diagnosing ME/CFS;
  • Benefits of establishing a biobank to advance research;
  • Ways to improve clinical care for ME/CFS patients; and
  • How to initiate, support, sustain and advance research on ME/CFS.

"There is an urgent need to get to the bottom of this devastating disease. To do this, we need many people looking at it from different perspectives and sharing as many ideas as possible so that we are better able to understand ME/CFS at the molecular level," explains Dr. Ronald Davis, Professor, Biochemistry and Genetics and Director, Stanford Genome Technology Center.

Speakers include Dr. Jonas Bergquist, Professor, Uppsala University; Dr. Alison C. Bested, Clinical Director, Institute for Neuro-Immune Medicine at Nova Southeastern University; Dr. Peter Rowe, Director, Children's Center Chronic Fatigue Clinic, Johns Hopkins University; Dr. Eleonor Stein, Clinical Assistant Professor, Department of Psychiatry, University of Calgary; and Dr. Derya Unutmaz, Professor, The Jackson Laboratory.

The conference is made possible through the support of the Canadian Institutes of Health Research and other partners.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
While severe chronic fatigue is one well-known symptom, ME/CFS affects a person's cognitive and physical abilities and primarily strikes the neurological, endocrine and immune systems. A 2015 Statistics Canada unpublished Canadian Community Health Survey (CCHS) reports that just over 560,000 patients were diagnosed with ME/CFS, an increase of 37.6% from 2014.  In Quebec, tens of thousands of individuals are affected. ME/CFS is recognized by the World Health Organization.

To view the program, click here.

 

SOURCE Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Canadian Collaborative Team Conference

Hogan Pharmacy First In Canada Offering SAFE RX Locking Prescription Vials (LPVs)

 

SARNIA, ON-BASED PHARMACY CHAIN ADDRESSES OPIOID CRISIS AND PEDIATRIC POISONINGS ASSOCIATED WITH MEDICATION

SARNIA, ON, April 25, 2018 /CNW/ - Hogan Pharmacies throughout southern Ontario are taking a leadership role in addressing two major health issues – the opioid epidemic and unintentional pediatric medicine poisonings.

Today, Hogan Pharmacy became the first pharmacy chain in Canada to offer SAFE RX® Locking Prescription Vials (LPVs™). "LPVs™ provide a more secure medication storage option for anyone filling a prescription. Secure storage helps prevent accidental access to medications and intentional pilfering, which is a leading source for teen prescription drug abuse and opioid addiction," said Darryl Moore, Co-Owner of Sarnia-based Hogan Pharmacy Group.

According to a recent Government of Canada report, there were 2,946 apparent opioid-related deaths in Canada in 2016. In only nine months, from January to September 2017, there were at least 2,923 apparent opioid-related deaths and "it is expected that this count will rise as additional data become available," added Moore.

"Health ministers and key stakeholders have publicly committed to working within their respective areas of responsibility in a coordinated and comprehensive response to address problematic opioid use. The first pillar of the response is prevention, which includes improving prescribing practices and better informing Canadians about the risks of opioids," said Dean Miller, President/CEO, Whole Health Pharmacy Partners of Markham, ON.

"The SAFE RX® LPV™ is an affordable and sensible solution to keep medicine out of the wrong hands. The four-number lock is child-safe, pilfer-resistant and tamper-evident, providing Canadians with peace of mind that they have done everything they can to protect their medicine from both accidental ingestion and intentional pilfering," said Andy Cipra, Chief Commercial Officer, SAFE RX®.

Hogan Pharmacies across Ontario will have SAFE RX® LPVs™ available for dispensing and will be able to encode patients' desired four-digit codes into the lock right at the pharmacy.

SAFE RX® LPVs™ won the prestigious Product Showcase Award in the pharmacy supplies and equipment category at the National Association of Chain Drug Stores' 2017 Total Store Expo, the largest pharmacy industry trade show in North America.

ABOUT HOGAN PHARMACY
Providing pharmacy services to Lambton County since 1951, Hogan Pharmacy first located in St. Joseph's Hospital. In 1982, Hogan's relocated to 457 London Road in Sarnia, adjacent to Bluewater Health Hospital. Co-owned by Darryl Moore and Jeff Churchman, the Hogan Pharmacy Group has grown to eight independently-owned pharmacies, all dedicated to the profession with a focus on complete patient wellness.

ABOUT SAFE RX® (www.safe-rx.com)
Safe Rx® LPVsTM keep medicine from falling into the wrong hands. Developed by experts and endorsed by industry leaders, Safe Rx® LPVsTM protect individuals, families and communities from improper access to medication. The tamper-evident and pilfer resistant locking medicine vials are designed for use in dispensing and are engineered for extremely low incremental fill time and easy workflow adaption. SAFE RX LLC is a wholly owned subsidiary of Secure Medication Systems LLC. For more information please visit www.safe-rx.com.

SOURCE SAFE RX®

Delta 9 Marks 4/20 By Obtaining License for Cannabis Oil Production

 

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/

WINNIPEG, April 24, 2017 /CNW/ - DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") is pleased to announce that Health Canada has approved the Company's application for an amendment to its cannabis production and sale license which will allow it to produce bottled cannabis oils under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). The license amendment was issued on April 20, 2018 and is valid until August 30, 2019.

"This is another important step for Delta 9 in preparing for legalization in Canada, but also in working with our partners in Germany, where we have signed an export agreement," said Delta 9 CEO John Arbuthnot.

Delta 9 announced the signing of a non-binding letter of intent on March 27, 2018 with Global Group Kalapa S.L. and Canpharma GMBH for the exportation of medical cannabis and cannabis oils to Germany. As part of that agreement, Delta 9 agreed to produce cannabis oil, and agreed to become GMP (Good Manufacturing Process) certified.

Also this week Delta 9 engaged QNR Associates of Edmonton, Alberta to help plan the upgrade of the Company's Winnipeg facility to the standards required of GMP certification. Currently the facility is certified under the GPP (Good Production Practices) protocol, which is required under the ACMPR program in Canada.

The Company also recently announced that it is building a second cannabis production facility in Calgary, Alberta in partnership with Westleaf Cannabis Inc., known as the "Delta West" facility. This facility will include a GMP certified lab for the production of cannabis oil and all legally allowed cannabis extracts and derivatives.

This month Delta 9 also submitted its application for cannabis retail outlets in Saskatchewan under the Provincial Government's RFP process, which closed on April 10, 2018.

"Our management believes there is a strong and generally underserved market in the Prairie Provinces, and we have focused our goals on becoming a market leader in Manitoba, Saskatchewan and Alberta," said Arbuthnot. "Our expansion in all of these provinces is actually proceeding faster than expected, and obtaining our license for cannabis oils was one more crucial step on our path."

About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) Delta 9's expansion plans; (ii) Delta 9's production of cannabis and cannabis oils; and (iii) demand for and sale of Delta 9's products. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that Delta 9's currently contemplated expansion and development plans may cease or otherwise change, Delta 9's production of cannabis may be lower than expected, Delta 9 may not obtain the required approvals from Health Canada, demand for Delta 9's products may be lower than anticipated, Delta 9's cost to produce its grow pods may be higher than expected and all other risk factors set forth in the filing statement of Delta 9 dated October 25, 2017 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

SOURCE Delta 9 Cannabis Inc.